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Abstract
Background: The major cause of death in the city of São Paulo (SP) is cardiac events. At its periphery, in-hospital mortality 
in acute myocardial infarction is estimated to range between 15% and 20% due to difficulties inherent in large metropoles.
Objective: To describe in-hospital mortality in ST-segment elevation acute myocardial infarction (STEMI) of patients admitted 
via ambulance or peripheral hospitals, which are part of a structured training network (STEMI Network).
Methods: Health care teams of four emergency services (Ermelino Matarazzo, Campo Limpo, Tatuapé and Saboya) of the 
periphery of the city of São Paulo and advanced ambulances of the Emergency Mobile Health Care Service (abbreviation in 
Portuguese, SAMU) were trained to use tenecteplase or to refer for primary angioplasty. A central office for electrocardiogram 
reading was used. After thrombolysis, the patient was sent to a tertiary reference hospital to undergo cardiac catheterization 
immediately (in case of failed thrombolysis) or in 6 to 24 hours, if the patient was stable. Quantitative and qualitative variables 
were assessed by use of uni- and multivariate analysis. 
Results: From January 2010 to June 2011, 205 consecutive patients used the STEMI Network, and the findings were as follows: 
87 anterior wall infarctions; 11 left bundle-branch blocks; 14 complete atrioventricular blocks; and 14 resuscitations after 
initial cardiorespiratory arrest. In-hospital mortality was 6.8% (14 patients), most of which due to cardiogenic shock, one 
hemorrhagic cerebrovascular accident, and one bleeding.
Conclusion: The organization in the public health care system of a network for the treatment of STEMI, involving 
diagnosis, reperfusion, immediate transfer, and tertiary reference hospital, resulted in immediate improvement of 
STEMI outcomes. (Arq Bras Cardiol 2012;99(5):1040-1048)
Keywords: Myocardial infarction; guidelines; emergencies; quality of health care.
Consequently, there is great difficulty in the clinical and 
electrocardiographic diagnosis of AMI, which delays the 
beginning of the treatment for cardiovascular emergencies. 
The ST-segment elevation AMI (STEMI) has immediate 
myocardial reperfusion as the basis of its treatment. The 
difficulties previously mentioned in the city of São Paulo 
contribute to maintain the mean mortality due to STEMI 
ranging from 15% to 20%5. Such figures are very different 
from the mortality found in centers that perform systematic 
reperfusion, where mortality ranges from 5% to 7%6-8.
This article aimed at describing the pilot operation of the 
STEMI network in the periphery of the city of São Paulo. 
In addition, this study also provides the results obtained at 
the hospital of the public health care system, which is part 
of the project, after systematization of STEMI management.
Methods
This report, as a registry, comprises all cases diagnosed 
in the STEMI network and treated as STEMI according to a 
protocol, with no exclusion. The Hospital São Paulo of the 
Universidade Federal de São Paulo (Unifesp) was the tertiary 
Introduction
Acute myocardial infarction (AMI) is the major cause 
of death in the majority of developed countries, which 
is expected to occur in the next decades in developing 
countries1-2. In Brazil, data of the Unified Public Health 
Care System (abbreviation in Portuguese, SUS) have shown 
that cardiovascular causes account for 35% of the deaths, 
cerebrovascular accident (CVA) being the major cause in 
the North and Northeastern regions, and AMI in the cities 
of São Paulo, Rio de Janeiro, Curitiba, and Porto Alegre3-4.
In São Paulo, a city with more than 11 million 
inhabitants, the distribution of emergency services (ESs) 
and public hospitals is heterogeneous, with scarcity 
in peripheral zones. That heterogeneity of resources 
also involves the quality of the medical care provided. 
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reference hospital of the project. No patient was denied 
transfer to another institution. This project was discussed 
with and approved by the Emergency Mobile Health Care 
Service (abbreviation in Portuguese, SAMU) at the Brazilian 
Agency of Sanitary Surveillance (abbreviation in Portuguese, 
Anvisa) and the Ethics Committees of the São Paulo City 
Hall and Unifesp. The protocol uses recommendations of 
Brazilian and international guidelines9-11, and is the same 
adopted for the management of STEMI at Unifesp regarding 
the indications for thrombolytic agents, primary and rescue 
percutaneous transluminal coronary angioplasty (PTCA), 
and pharmacoinvasive therapy. The project of the STEMI 
network and the diagnostic and treatment protocol are 
briefly described.
Organization of the STEMI network
Initially, a 24-hour central office for electrocardiogram 
(ECG) reading was installed at the Hospital São Paulo 
to receive exams sent from 126 SAMU ambulances 
(16 advanced and 110 basic ambulances), covering the entire 
São Paulo metropolitan region. The ECGs are transmitted to 
the central office via mobile phone, fixed phone or internet, 
and immediately interpreted by a team of cardiologists, by 
using guidelines for STEMI ECG diagnosis9,12. The ECG reports 
are sent to the mobile phone of the transmitting ambulance; 
a study on that topic has already been published13.
In addition to advanced ambulances, the São Paulo 
Municipal Health Secretariat has made the fibrinolytic 
agent tenecteplase (TNK) available at four municipal ESs 
with a history of a large number of infarcted patients: 
Ermelino Matarazzo, Campo Limpo, Tatuapé, and Saboya. 
The medical and nursing teams of those ESs were trained 
and updated on the clinical diagnosis of acute coronary 
syndrome, ECG recognition of STEMI, and indications of 
thrombolytic agents and primary PTCA in STEMI. A direct 
and immediate contact via a dedicated and exclusive 
mobile phone line was established between the advanced 
ambulances or the four ESs assessed and the Coronary Unit 
(COU) of the Hospital São Paulo. Thus, a patient diagnosed 
with STEMI, who was at an ES or SAMU ambulance 
and could be in a catheterization laboratory in less than 
90 minutes was referred for primary PTCA. If the advanced 
ambulance was very far away or if the estimated travel time 
for a patient at one of the ESs was longer than 90 minutes, 
he/she would receive TNK; after thrombolysis, the patient 
would be immediately transferred to the Hospital São Paulo, 
and would undergo either rescue PTCA, if necessary, or 
cardiac catheterization within 6 to 24 hours, if clinically 
stable (Figure 1). The thrombolytic agent was used for as 
much as three hours in the advanced ambulances or for as 
much as six hours in the municipal ESs. The dose of TNK 
ranged from 30 mg to 50 mg, meeting the known criteria 
for indication and contraindication of fibrinolytic drugs. In 
addition to TNK, the patients received as adjuvant therapy 
and according to the Brazilian and international guidelines 
the recommended doses of morphine, low-molecular weight 
heparin (properly corrected to weight and renal function), 
and oral medications, such as nitrate, aspirin, antiplatelet 
drugs, and beta-blockers (if Killip I)9-11. The patients of the 
ambulances underwent antiplatelet therapy after their arrival 
at the ES or tertiary reference hospital.
Figure 1 – STEMI network – Flowchart;  SAMU: Emergency Mobile Health Care Service; TNK: tenecteplase; ES: emergency service; ECG: electrocardiogram
Flowchart
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Definitions
This study adopted the definitions used in the already cited 
guidelines9-11. Primary PTCA was defined as initial mechanical 
reperfusion during cardiac catheterization for a STEMI with 
no previous use of fibrinolytic drugs or glycoprotein IIB/
IIIa inhibitors. Rescue PTCA was defined as an emergency 
cardiac catheterization due to ineffective thrombolysis, 
characterized by persistence of pain at an intensity of at least 
50% of that at onset or persistence of at least 50% of the 
ST-segment elevation on ECG in the leads initially involved. 
Pharmacoinvasive strategy was defined as the use of full-
dose chemical thrombolysis, followed by routine cardiac 
catheterization within 6 to 24 hours, even in stable patients. 
Complications  
The complications were defined according to the 
already cited guidelines, and all data from the patients 
were entered to an Excel sheet developed for that purpose 
and comprising 91 pieces of information on each case12. 
The following complications are described in this article: 
initial cardiorespiratory arrest (CRA); Killip II-IV; complete 
atrioventricular block (CAVB); pain recurrence; and new 
ECG changes or changes in cardiac markers during disease 
progression. The diagnosis of ischemic or hemorrhagic CVA 
was confirmed by use of computed tomography or cerebral 
magnetic resonance imaging.
Statistical analysis
Regarding the data collected, quantitative variables were 
expressed as mean and standard deviation and compared 
by use of Wilcoxon test or Student t test. The chi-square test 
was used to compare the qualitative variables regarding in-
hospital mortality at the Ermelino Matarazzo ES before and 
after establishing the STEMI network. Uni- and multivariate 
analyses to identify factors possibly related to in-hospital death 
were performed.
Results
This study assessed 205 consecutive patients cared for at 
the STEMI network, with no exclusions, and who underwent 
the complete sequence, that is, from diagnosis to transfer to 
the tertiary reference hospital, from January 2010 to June 
2011. Of those 205 patients, 190 (92.7%) underwent cardiac 
catheterization. Figure 2 shows the flowchart of the case series, 
in which only 38 (18.5%) patients with STEMI were referred for 
initial cardiac catheterization without previous thrombolysis. 
The other 167 patients with STEMI (81.5%) underwent 
thrombolysis; 43 of them (25.7%) underwent rescue PTCA 
and the others underwent elective cardiac catheterization 
with stent implantation, when necessary.
The origins of the patients were as follows: SAMU 
ambulances, 46 patients; Ermelino Matarazzo ES, 59; Tatuapé 
ES, 41; Saboya ES, 31; and Campo Limpo ES, 24. Four other 
patients originated from other ESs, were diagnosed via the ECG 
central office, and were transferred in SAMU ambulances13.
Demography 
The demographic data are shown in Table 1. Most 
patients (71.7%) were males. Their mean age was 58.8 years 
(range, 33 to 88), and 24 patients (11.7%) were over the age 
of 75 years. Their characteristics were as follows: 63.4% had 
hypertension; 31.7% had diabetes; 49.2% smoked; 15.1% 
had had a previous AMI; and 7.8% had had a previous CVA. 
Seventeen patients had an initial heart rate over 100 beats 
Figure 2 – STEMI network – Flowchart of the cases; SAMU: Emergency Mobile Health Care Service; TNK: tenecteplase; AMAs; TPA: Tissue plasminogen activator; 
SK: streptokinase; PTCA: percutaneous transluminal coronary angioplasty
Flowchart of the cases
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per minute, and 16 (7.8%) had blood pressure levels under 
100 mm Hg. 
Regarding initial ECG, an ST-segment elevation greater 
than 1 mm was observed in two or more leads in the 
following walls: anterior, 87; inferior, 56; and lateral, dorsal 
or combinations, 51. Involvement of the right ventricle (RV) 
was observed in 12 patients, and complete left bundle-branch 
block in 11 patients.
Coronary reperfusion method
Thrombolytic agents were used in 167 patients, TNK in 
almost all of them. Only four patients did not receive TNK, 
because of lack of immediate availability at the time of the 
infarction, as follows: in one patient, the thrombolytic used 
was tissue plasminogen activator (t-PA); and, in the other 
three, streptokinase (SK). No death occurred during patients’ 
transfer to the tertiary reference hospital, either inter-hospital 
or pre-hospital transfer. However, one patient had CRA on 
the street and was resuscitated by the SAMU team, arriving 
alive at the tertiary reference hospital. That patient underwent 
cardiac catheterization, which evidenced occlusion of the right 
coronary artery, being submitted to PTCA. The patient had 
neurological complications and died.
Primary PTCA was indicated as the procedure of choice 
to 38 patients, in accordance with the flowchart in Figure 1, 
but was effectively performed in 22 patients. In the remaining 
16 patients, PTCA was not performed due to the following 
reasons: three patients showed a residual lesion of little 
importance and evidence of distal thrombus in the reperfused 
coronary artery; two patients had only coronary ectasia and 
slow flow; six patients showed occlusion in small vessels, such 
as the diagonal artery, posterior descending artery, and second 
marginal branch of the circumflex artery, or diffuse lesions 
with poor distal coronary bed; two patients had severe lesion 
in the left main coronary artery not amenable to PTCA; and 
three patients did not undergo cardiac catheterization after 
assessment at arrival at the reference hospital (Figure 2).
Cardiac catheterization was routinely performed in 
patients undergoing previous chemical thrombolysis, and 
in almost all cases within 6 to 24 hours after receiving the 
fibrinolytic agent. Of the 167 thrombolysed patients, 12 did 
not undergo cardiac catheterization because of the presence 
of either other morbid conditions contraindicating the exam 
or a recent exam. Cardiac catheterization was performed on 
an emergency basis (rescue) in 43 patients (25.7%). In the 
remaining 112 thrombolysed patients, cardiac catheterization 
was performed under stable conditions. Of the 205 patients, 
155 (75.6%) underwent a pharmacoinvasive strategy, either 
elective or rescue. Stents were placed in 152 patients (all bare-
metal stents), and seven balloon dilations were performed, 
corresponding to 77.5% of the immediate percutaneous 
intervention in the entire sample.
Complications of STEMI or of its invasive management
The following complications were observed (Table 2): 
recurrence of chest pain, 15 patients (7.3%); reinfarctions, 
three patients (1.5%); congestive heart failure, 20 patients 
(9.7%); CAVB, 14 patients (6.8%); Killip II-IV, 53 patients 
(25.8%); cardiogenic shock, 15 patients (7.3%); use of 
intraaortic balloon, 12 patients (5.8%); hemorrhagic CVA, one 
Table 1 – Patients’ characteristics and risk factors
Characteristics n = 205 %
Mean age 58.8  (32 ± 88) -
> 75 years 24 11.7
Male 147 71.7
Female 58 28.3
Heart rate > 100 bpm 17 8.3
Blood pressure < 100 mm Hg 16 7.8
Killip II - IV 53 25.8
Smoking habit 101 49.2
Diabetes mellitus 65 31.7
SAH 130 63.4
Family history for CVD 55 26.8
Dyslipidemia 113 55.1
Previous AMI 31 15.1
Peripheral vascular disease 22 10.7
Chronic renal failure 23 11.2
Previous CVA 16 7.8
 Killip II - IV: Killip and Kimball classification; CVD: cardiovascular disease; SAH: systemic arterial hypertension; AMI: acute myocardial infarction; CVA: 
cerebrovascular accident
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patient (0.5%); and ischemic CVA, one patient (0.5%). The 
complications due to the hemodynamic study were as follows: 
three patients (1.5%) had severe bleeding at the vascular access 
site, two of whom required transfusion; and one patient had a 
femoral pseudoaneurysm, corrected with surgery. In addition, 
the following were observed: seven minor bleedings; one 
ventricular fibrillation on the catheterization table, which was 
promptly reverted; and partial displacement of one thrombus 
from an ostial lesion of the anterior descending artery to the 
circumflex artery, causing its occlusion and irreversible CRA.
Mortality 
In this consecutive case series of 205 patients with STEMI, 
diagnosed either in an ambulance or at ESs of the periphery 
of the São Paulo city and transferred to a public reference 
hospital, 14 in-hospital deaths (6.8%) occurred, as shown in 
Table 3. Almost all deaths involved either elderly patients or 
situations of low cardiac output. In addition, other deaths 
were as follows: one sudden death prior to hospital discharge; 
one death due to upper gastrointestinal hemorrhage; one due 
to neurological injury following CRA at home at the beginning 
of AMI; and one due to hemorrhagic CVA. Univariate 
analysis was used to identify elements related to in-hospital 
death, and, later, only the factors that remained significant 
(p < 0.01) were used on multivariate analysis. The items 
identified, their respective odds ratios, and p values were 
as follows: previous CVA (OR 8.7; p = 0.002); occluded 
infarct-related artery (OR 12.1; p = 0.002); CAVB (OR 6.23; 
p = 0.01); use of intraaortic balloon (OR 11.75; p = 0.001); 
myocardial flow index (blush) of zero on the initial injection 
in the infarct-related artery (OR 13.7; p = 0.001); and 
cardiogenic shock, the best predictor (OR 308.3; p < 0.001). 
On the final adjustment of the multivariate analysis, all 
variables identified (except previous CVA) were associated 
with the presence of cardiogenic shock.
Discussion
Mortality due to acute coronary syndrome, especially 
STEMI, is a severe public health problem, due to its high 
prevalence and the fact that it is a permanent challenge in 
great metropoles, requiring several levels of integration of 
the health care system. Unfortunately, the price paid in such 
situations, which lack organization of the general health care 
provided, is significantly higher morbidity and mortality5. 
To increase the reperfusion rate is extremely important to 
improve the results of STEMI therapy: although there is no 
doubt that primary PTCA provides better coronary patency, 
with better distal flow, smaller residual lesion, and lower 
mortality as compared with the use of fibrinolytic drugs14-15, 
the systematic use of primary PTCA for all STEMI patients 
involves considerable logistic difficulties, especially in great 
metropoles with chaotic traffic, large distances from the 
periphery to the area with higher hospital concentration, 
and heterogeneous 24/7 operation of catheterization 
laboratories. It is worth noting that this is not an exclusively 
Brazilian problem, it also occurs in developed countries. 
Consequently, several recent publications have shown 
that PTCA performed within 60 minutes is the reperfusion 
strategy in around 20% to 30% of all STEMI cases7,12,13,16-18.
The STEMI network project aimed at standardizing the 
steps usually accounting for the delay in the treatment 
of AMI or its complications: rapid clinical diagnosis; 
immediate ECG for the patient with chest pain, with reading 
support from an ECG central office if necessary; immediate 
definition of management (primary PTCA or TNK use); 
immediate use of therapeutic adjuvants; and immediate 
availability of a reference hospital, even for stable patients. 
In addition, the project systematically comprised rescue 
PTCA and cardiac catheterization within 6 to 24 hours for 
stable patients. This option was considered in the 2010 
European Society of Cardiology guidelines on myocardial 
Table 2 – Complications
Complications n = 205 %
CRA - ventricular fibrillation 14 6.8
Recurrent angina 15 7.3
Reinfarction 3 1.5
Congestive heart failure 20 9.8
Cardiogenic shock 15 7.3
Intraaortic balloon 12 5.8
Right ventricular infarction 12 5.8
Complete atrioventricular block 14 6.8
Major bleeding 3 1.5
Minor bleeding 7 3.4
Blood transfusion 12 5.8
Hemorrhagic CVA 1 0.5
Ischemic CVA 1 0.5
CRA: cardiorespiratory arrest; CVA: cerebrovascular accident
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revascularization, in which pharmacoinvasive therapy 
was ranked class I and level of evidence A for STEMI, 3 to 
24 hours after reperfusion13,19,20,21-25.
The STEMI network had extremely promising results for 
an initial project, operationally and effectively involving 
several links of a previously non-operating chain. The 
COU-dedicated mobile phone eliminated the problems of 
contact delay and there was neither difficulty nor refusal of 
admission at the tertiary reference hospital.
The 205 patients with STEMI in this sample represented 
the severity profile usually observed in that condition, as we 
found 31.7% of diabetic patients, 63.4% of hypertensives, 
and almost half of the sample (45,2%) of active smokers. In 
addition, 15.1% and 7.8% of the patients had already been 
diagnosed with AMI and CVA, respectively. The following 
were also observed: 12 patients with AMI of the RV; 
14 patients with CAVB; 14 CRA; and 15 cardiogenic shocks. 
As expected, due to the logistic difficulties of the city of 
São Paulo and the distances between the centers involved in 
the STEMI network, only 18.5% of the sample was directly 
referred for cardiac catheterization to undergo primary PTCA. 
The remaining patients (81.5%) received a thrombolytic agent, 
and the contact for their transfer was immediately performed, 
even when they were stable. On the other hand, of the 
46 patients transferred in the SAMU ambulances, only eight 
(20%) underwent pre-hospital thrombolysis, a number that, 
although low, is frequently found in other countries26. It is worth 
noting that almost 25% of the thrombolysed patients required 
rescue PTCA, some still while in the ambulance (they left 
their origin stable and, on the way, their ST-segment elevation 
worsened, pain recurred, or hemodynamic instability occurred), 
emphasizing the need for immediate transfer to a reference 
hospital after thrombolysis. Only 12 patients were referred for 
coronary artery bypass graft surgery during hospitalization (6.3% 
of the 205 patients). 
The initial results of the STEMI network project were 
extremely encouraging because in-hospital mortality was only 
6.8%. The sequence comprising clinical diagnosis, rapid ECG 
interpretation, decision about the use of either fibrinolytic drugs 
or primary PTCA, TNK use, and transfer with systematic cardiac 
catheterization, performed immediately or within 6 to 24 hours, 
seems to have improved the outcome of those patients. 
A specific analysis of the ES of the Hospital Ermelino 
Matarazzo was performed, comparing the results of in-hospital 
mortality at the institution in 2009, before the STEMI network, 
and that in the 2010-2011 period, with the STEMI network 
installed. The Hospital Ermelino Matarazzo was chosen because 
it had the largest case series and the best records on hospital 
admission and discharge. In 2009, in 88 STEMIs treated at the 
Hospital Ermelino Matarazzo, mortality was 26.1%, while in 
the 2010-2011 period, among all 65 patients who initiated 
treatment there and completed it at the Hospital São Paulo, 
the in-hospital mortality was 6.1% (Figure 3 -  pre and post χ2 
: 8.94; p = 0.0028).
It is worth emphasizing the importance of those results, 
because they were obtained in patients of the SUS, from the 
periphery of the city of São Paulo, involving the municipal and 
federal public health care systems. In addition, they confirm 
recent publications showing that organizing a myocardial 
infarction network determines an immediate improvement 
in outcomes, which motivated an on-going study (STREAM 
study), comparing directly pharmacoinvasive therapy versus 
primary PTCA27-35,36.
This study, however, shows that any project to treat STEMI 
should consider and interpret local needs and characteristics, 
and not only copy models of distinct realities. 
Table 3 – Specification of the patients who died and their major causes of death
PATIENT AGE SEX REPERFUSION CAUSE OF DEATH
1- 87 F Mechanical Sudden death
2- 86 F Not performedLeft main coronary artery - IAB Cardiogenic shock
3- 55 M Chemical Cardiogenic shock
4- 53 M Chemical Cardiogenic shock
5- 50 M Chemical Hemorrhagic CVA
6- 67 M Chemical Cardiogenic shock
7- 83 F Chemical Septic shock
8- 76 M Chemical Upper gastrointestinal hemorrhage 
9- 56 M Mechanical Neurological injury after CRA on the street 
10- 56 F Chemical Cardiogenic shock
11- 49 M Chemical Sudden death before hospital discharge
12- 82 F Chemical Cardiogenic shock
13- 77 F Mechanical Cardiogenic shock
14- 76 M Chemical Cardiogenic shock
F: female; M: male; CVA: cerebrovascular accident; IAB: Intraaortic balloon; CRA: cardiorespiratory arrest.
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Limitations
This was not a randomized blind study. It does not suggest 
that the results obtained are definitive or that the strategy is 
better or equivalent to the systematic use of primary PTCA. 
This study involved municipal ESs and ambulances, which, 
after training, submitted the cases identified as STEMI to 
the tertiary reference hospital. We could not assess whether 
there were cases in which the tertiary reference hospital was 
not contacted. In addition, the project did not encompass 
the entire public health care system of the city. One of the 
positive aspects of this case series is that no patient was denied 
admission to the tertiary reference hospital, being, thus, a 
consecutive case series, similar to a registry, with no exclusion 
factors, such as age, sex, and renal function. 
Conclusion
Systematization of the treatment of STEMI with training of 
the teams involved in the initial care, use of thrombolytic and 
antiplatelet agents according to protocols, and patient’s transfer to 
the tertiary reference hospital showed in-hospital mortality lower 
than that observed for patients with STEMI treated conventionally 
in the municipal public health care system of the city of São Paulo.
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